Evaluation of Commercially Available Anti–Dengue Virus Immunoglobulin M Tests
Figure 1. A) Sensitivity and B) specificity of 5 microplate ELISAs used at laboratories in 7 countries for detecting immunoglobulin (Ig) M against dengue virus compared with reference solid-phase IgM antibody-capture ELISAs developed by the Centers for Disease Control and Prevention (Atlanta, GA, USA) and the Armed Forces Research Institute of Medical Science (Bangkok, Thailand). Mean sensitivities and specificities for the 5 tests are shown in parentheses. C) Sensitivity and D) specificity of 4 rapid diagnostic tests used at laboratories in 7 countries for detecting IgM against dengue virus compared with solid-phase IgM antibody-capture ELISAs. Mean sensitivities and specificities for the 4 tests are shown in parentheses.